#United States #healthcare #Alpharetta #Avanos Medical #AIP

Acquisition of Avanos Medical by American Industrial Partners

On July 27, 2026, American Industrial Partners (AIP), an investment firm oriented towards industrial operations, officially concluded its acquisition of Avanos Medical, Inc. This deal, valued at approximately $1.272 billion, is aimed at significantly bolstering AIP's presence in the healthcare sector.

Transaction Details

As per the merger agreement, shareholders of Avanos will receive $25.00 in cash for each share of common stock they hold. Once the transaction is complete, Avanos’ common stock will stop trading on the New York Stock Exchange as the company transitions to private ownership. This pivotal move highlights AIP’s strategic plan to harness Avanos' innovative spirit while providing them the support necessary for future growth.

Joel Rotroff, a Partner at AIP, expressed enthusiasm about the partnership, stating, "We are excited to partner with Avanos to deliver a compelling platform for continued growth in the medical technology sector. We are confident that by leveraging AIP's deep operational expertise and resources, Avanos will be in a strong position to build on its momentum and achieve long-term success."

On the other hand, Avanos CEO Dave Pacitti echoed this sentiment, noting, "Avanos enters this next chapter with real momentum, and AIP is the right partner to help us build on it. AIP's operational depth means we can move faster on the innovation roadmap our teams have already put in motion and do it with resources to match our ambition. I thank our employees for their continued dedication and commitment to providing solutions that enable patients to get back to what matters."

About Avanos Medical

Avanos Medical focuses on providing advanced medical technology solutions aimed at improving patient outcomes. The company, headquartered in Alpharetta, Georgia, specializes in addressing critical healthcare needs, from nutrition support in hospitals to recovery assistance following surgery. This acquisition not only promises to enhance Avanos’ operational capabilities but also aims to further its ambition of reducing opioid use in postoperative care. Avanos is recognized for its leading market positions in multiple categories, emphasizing innovative medical device development and manufacturing on a global scale.

About American Industrial Partners

AIP brings to the table a formidable experience and expertise in the industrial sector, supervising approximately $17.8 billion in assets. The firm's investment strategy is focused on acquiring quality businesses and collaborating closely with management teams. This helps to implement impactful operational strategies intended to build long-term value. Over the years, AIP has completed more than 145 acquisitions and has a history of successful investments that span across different economic cycles. As of March 31, 2026, AIP's portfolio companies collectively generate annual revenues of around $32 billion and employ an extensive workforce of over 74,000 individuals.

The partnership between AIP and Avanos Medical is poised to foster innovation and elevate the standards of medical technology, ensuring that both entities thrive in a rapidly evolving healthcare landscape.

For additional information regarding Avanos Medical and its product offerings, visit the official website at avanos.com. Engaging updates can also be found on Avanos Medical’s social media platforms including X, LinkedIn, and Facebook.